Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended
Mar. 31, 2021	Mar. 31, 2020
Income Statement [Abstract]
Revenue	$ 113,479	$ 68,518
Cost of revenue	61,328	36,359
Gross profit	52,151	32,159
Operating expenses:
Research and development	13,333	9,530
Sales and marketing	11,992	9,417
General and administrative	26,863	16,096
Total operating expenses	52,188	35,043
Operating loss	(37)	(2,884)
Other expense, net	(5,611)	(906)
Loss before income taxes	(5,648)	(3,790)
Income tax benefit	332	2,732
Net loss	$ (5,316)	$ (1,058)
Net loss per share, basic and diluted (in usd per share)	$ (0.21)	$ (0.04)
Weighted average number of common shares outstanding, basic and diluted (in shares)	25,015,948	23,563,569

The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 924
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-URI http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.2(a),(d))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227